Article Contents ::
- 1 The Brand Name MEGAMOST SOFTGEL Has Generic Salt :: OMEGA-3
- 2 MEGAMOST SOFTGEL Is From Company Sanat Priced :: Rs. 62
- 3 MEGAMOST SOFTGEL have OMEGA-3 is comes under Sub class #N/A of Main Class #N/A
- 4 Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name MEGAMOST SOFTGEL Has Generic Salt :: OMEGA-3
MEGAMOST SOFTGEL Is From Company Sanat Priced :: Rs. 62
MEGAMOST SOFTGEL have OMEGA-3 is comes under Sub class #N/A of Main Class #N/A
Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
| Salt Name : OR Generic Name | Form | Price : MRP /Probable | Packing | ||
| OMEGA-3 | CAP | Rs. 62 | 10 |
| Brand Name | Company / Manufacturers | Strength | Unit | Price / 10 |
| MEGAMOST SOFTGEL | Sanat | 273MG,100MG,25IU.,15MG,15MG,3MG,100MCG,70MCG,5000IU. | 10 | Rs. 62 |
| Company Brand Name | Salt Combination | Main Medical Class | Sub Medical Class |
| From Sanat :: MEGAMOST SOFTGEL | OMEGA-3 | #N/A | #N/A |
Indications for Drugs ::
Dyslipidemia, Hypertriglyceridaemin,
Drug Dose ::
The daily dose is 4 grams per day. The daily dose may be taken as a single 4-gram dose (4 capsules) or as two 2-gram doses (2 capsules given twice daily).
Contraindication ::
Patients with known hypersensitivity (e.g., anaphylactic reaction) to LOVAZA or any of its components.
Drug Precautions ::
In patients with hepatic impairment, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels should be monitored periodically during therapy . In some patients, increases in ALT levels without a concurrent increase in AST levels were observed.
Drug Side Effects ::
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
Pregnancy category ::
3
Drug Mode of Action ::
Possibly inhibits acyl CoA: 1,2-diacylglycerol acyltransferase, increases peroxisomal beta-oxidation in liver; may decrease hepatic triglyceride synthesis; plasma lipoprotein lipase activity may increase.
Drug Interactions ::
0
